![Martin Maier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Maier
Director/Board Member at
PROQR THERAPEUTICS N.V.
Net worth: - $ as of 31/05/2026
Profile
Martin Maier currently works at Oligonucleotide Therapeutics Society, Inc., as Director, ProQR Therapeutics NV, as Member-Supervisory Board from 2024, and Alnylam Pharmaceuticals, Inc., as Senior Vice President-Oncology.
Dr. Maier received his doctorate degree in 1997 from Eberhard Karls Universität Tübingen.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Martin Maier active positions
| Companies | Position | Start |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director/Board Member | 22/05/2024 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2006 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Director/Board Member | - |
Training of Martin Maier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
- Stock Market
- Insiders
- Martin Maier
